Cargando…
Potential anti-tumor effect of a nanoliposomal antiPCSK9 vaccine in mice bearing colorectal cancer
INTRODUCTION: Inhibition of proprotein convertase subtilisin/kexin 9 (PCSK9) is an effective therapeutic tool for lowering low-density lipoprotein cholesterol (LDL-C). There is no available evidence on the efficacy and safety of PCSK9 inhibitors in non-cardiovascular diseases, particularly cancer. T...
Autores principales: | Momtazi-Borojeni, Amir Abbas, Nik, Maryam Ebrahimi, Jaafari, Mahmoud Reza, Banach, Maciej, Sahebkar, Amirhossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524180/ https://www.ncbi.nlm.nih.gov/pubmed/31110520 http://dx.doi.org/10.5114/aoms.2019.84732 |
Ejemplares similares
-
Effects of immunization against PCSK9 in an experimental model of breast cancer
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2019) -
Pre-Clinical Evaluation of the Nanoliposomal antiPCSK9 Vaccine in Healthy Non-Human Primates
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2021) -
Effects of immunisation against PCSK9 in mice bearing melanoma
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2019) -
Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2019) -
PCSK9 immunization using nanoliposomes: preventive efficacy against hypercholesterolemia and atherosclerosis
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2021)